CLAFLIN THOMAS M II 4
4 · POINT THERAPEUTICS INC · Filed May 24, 2004
Insider Transaction Report
Form 4
CLAFLIN THOMAS M II
Director
Transactions
- Award
Non-qualified stock option
2004-05-24$6.02/sh+10,000$60,200→ 35,000 totalExercise: $6.02From: 2004-05-24Exp: 2014-05-24→ Common Stock (10,000 underlying)
Holdings
- 883,335(indirect: Held by Black Diamond Fund, L.P.)
Common Stock